Correlation Between Bio Path and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bio Path and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Aerovate Therapeutics, you can compare the effects of market volatilities on Bio Path and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Aerovate Therapeutics.
Diversification Opportunities for Bio Path and Aerovate Therapeutics
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bio and Aerovate is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Bio Path i.e., Bio Path and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Bio Path and Aerovate Therapeutics
Given the investment horizon of 90 days Bio Path Holdings is expected to generate 10.55 times more return on investment than Aerovate Therapeutics. However, Bio Path is 10.55 times more volatile than Aerovate Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 61.00 in Bio Path Holdings on November 5, 2024 and sell it today you would earn a total of 20.00 from holding Bio Path Holdings or generate 32.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bio Path Holdings vs. Aerovate Therapeutics
Performance |
| Timeline |
| Bio Path Holdings |
| Aerovate Therapeutics |
Bio Path and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bio Path and Aerovate Therapeutics
The main advantage of trading using opposite Bio Path and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |